Cited by 37

The DOI matches its Crossref record.

Loss of Epidermal Langerhans Cells Occurs in Human Papillomavirus α, γ, and μ but Not β Genus Infections

Leong, Cheng Mee, Doorbar, John, Nindl, Ingo, Yoon, Han-Seung, Hibma, Merilyn H.·2010·Journal of Investigative Dermatology

Abstract

Human papillomaviruses (HPVs), which are contained in the alpha, beta, gamma, mu, and nu genera, differ in their oncogenic potential and their tropism for cutaneous or mucosal epidermis. Langerhans cells (LC), the only epidermal professional antigen-presenting cells, are readily detected in normal mucosal and cutaneous epithelium. The aim of this study is to determine whether LC loss, which has been reported for HPV16, occurs in other HPV genera and establish its significance in viral pathology. We found that, as for HPV16, LCs were reduced in lesions infected with high-risk mucosal (alpha7 and alpha9 species) and low-risk cutaneous (gamma and mu) types. Lesions infected with alpha10 low-risk genital types had reduced LC but contained epidermal LC patches, coincident with dermis-localized regulatory T cells (T-regs). In contrast to other genera, LCs were common in the epidermis, and T-regs occupied the dermis of the potentially high-risk cutaneous beta-HPV type infected lesions. Therefore, LC loss in the infected lesions occurred irrespective of tropism or oncogenic potential of the HPV type. LC depletion in the HPV-infected epidermis may create an environment that is permissive for viral persistence and in HPV lesions in which LCs are found, the presence of typically immunosuppressive T-regs may compensate for their continued presence.

Overview

Integrity signals

Registry

Crossref · 10.1038/jid.2009.266

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 21

  1. Brink, 2005, Development of a general-primer-PCR-reverse-line-blotting system for detection of beta and gamma cutaneous human papillomaviruses, J Clin Microbiol, 43, 5581, 10.1128/JCM.43.11.5581-5587.2005 · DOI
  2. Caberg, 2009, Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20, Cancer Immunol Immunother, 58, 39, 10.1007/s00262-008-0522-5 · DOI
  3. Caberg, 2008, Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes, Carcinogenesis, 29, 1441, 10.1093/carcin/bgn145 · DOI
  4. Cao, 2008, Local accumulation of FOXP3+ regulatory T cells: evidence for an immune evasion mechanism in patients with large condylomata acuminata, J Immunol, 180, 7681, 10.4049/jimmunol.180.11.7681 · DOI
  5. Cooper, 1990, Antigen presentation and T-cell activation in epidermodysplasia verruciformis, J Invest Dermatol, 94, 769, 10.1111/1523-1747.ep12874631 · DOI
  6. de Jong, 2004, Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6, Cancer Res, 64, 5449, 10.1158/0008-5472.CAN-04-0831 · DOI
  7. de Villiers, 2004, Classification of papillomaviruses, Virology, 324, 17, 10.1016/j.virol.2004.03.033 · DOI
  8. Dell’Oste, 2009, High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis, J Invest Dermatol, 129, 1026, 10.1038/jid.2008.317 · DOI
  9. Dillon, 2007, Resolution of cervical dysplasia is associated with T-cell proliferative responses to human papillomavirus type 16 E2, J Gen Virol, 88, 803, 10.1099/vir.0.82678-0 · DOI
  10. Fausch, 2005, Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation, J Immunol, 174, 7172, 10.4049/jimmunol.174.11.7172 · DOI · Paper page
  11. Guess, 2005, Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production, J Virol, 79, 14852, 10.1128/JVI.79.23.14852-14862.2005 · DOI
  12. Jiang, 2007, Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation, Immunity, 27, 610, 10.1016/j.immuni.2007.08.015 · DOI
  13. Karagas, 2006, Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin, J Natl Cancer Inst, 98, 389, 10.1093/jnci/djj092 · DOI
  14. Larregina, 2001, Dermal-resident CD14+ cells differentiate into Langerhans cells, Nat Immunol, 2, 1151, 10.1038/ni731 · DOI
  15. Matthews, 2003, Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin, J Virol, 77, 8378, 10.1128/JVI.77.15.8378-8385.2003 · DOI · Paper page
  16. Merad, 2002, Langerhans cells renew in the skin throughout life under steady-state conditions, Nat Immunol, 3, 1135, 10.1038/ni852 · DOI
  17. Middleton, 2003, Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers, J Virol, 77, 10186, 10.1128/JVI.77.19.10186-10201.2003 · DOI
  18. Peh, 2002, Life cycle heterogeneity in animal models of human papillomavirus-associated disease, J Virol, 76, 10401, 10.1128/JVI.76.20.10401-10416.2002 · DOI
  19. Pfister, 2003, Chapter 8: human papillomavirus and skin cancer, J Natl Cancer Inst Monogr, 31, 52, 10.1093/oxfordjournals.jncimonographs.a003483 · DOI
  20. Rubben, 1997, Clinical features and age distribution of patients with HPV 2/27/57-induced common warts, Arch Dermatol Res, 289, 337, 10.1007/s004030050201 · DOI
  21. Weissenborn, 2005, Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers, J Invest Dermatol, 125, 93, 10.1111/j.0022-202X.2005.23733.x · DOI

Metadata

Authors
Leong, C. M., Doorbar, J., Nindl, I., Yoon, H.-S., & Hibma, M. H.
Venue
Journal of Investigative Dermatology
Publisher
Elsevier BV
Published
2010-02
Volume
130
Issue
2
Pages
472-480
ISSN
0022-202X
Cited by
37
References
0
Language
en
Funders
  • Health Research Council of New Zealand
  • Cancer Society of New Zealand

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review